StockData
Achieve Life Sciences, Inc. logo

Achieve Life Sciences, Inc. (ACHV) stock

ACHVNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as QUIT
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$6.72+0.34 (+5.33%)

Close on Nov 6, 2026Market cap $691.50MP/E –Yield –

Achieve Life Sciences pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Achieve Life Sciences's pe ratio was 25.0× on Jan 31, 2017, against 52.9× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2017Jan 31, 201725.0×+2.7
2016Dec 30, 201622.3×+17.0
2015Dec 31, 20155.2×−47.6
2011Jul 29, 201152.9×–

More Achieve Life Sciences figures

See a number that looks wrong?